$EOCN
Galmed Pharmaceuticals Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Ramat Gan, Israel
EOCN chart
What traders are saying about $EOCN
Latest postsGalmed Pharmaceuticals Ltd. news
Galmed Pharmaceuticals Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$10.3M | -$7.5M | -$6.9M | -$17.9M |
| Diluted EPS | $2.39 | $8.08 | $30.00 | $127.80 |
| Total assets (year end) | $18.6M | $18.5M | $16.6M | $16.6M |
| Cash and equivalents (year end) | $4.0M | $4.7M | $2.9M | $2.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Galmed Pharmaceuticals Ltd.
- Ticker
- EOCN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ramat Gan, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1595353
Frequently asked questions
What exchange is Galmed Pharmaceuticals Ltd. listed on?
Galmed Pharmaceuticals Ltd. trades on the Nasdaq under the ticker symbol EOCN.
What industry is Galmed Pharmaceuticals Ltd. in?
Galmed Pharmaceuticals Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Galmed Pharmaceuticals Ltd. headquartered?
Galmed Pharmaceuticals Ltd.'s business address on file with the SEC is in Ramat Gan, Israel.
When does Galmed Pharmaceuticals Ltd.'s fiscal year end?
Galmed Pharmaceuticals Ltd.'s fiscal year ends on December 31.
How much revenue did Galmed Pharmaceuticals Ltd. report?
Galmed Pharmaceuticals Ltd. reported $0 in revenue for calendar year 2020, according to its SEC filings.